174 related articles for article (PubMed ID: 33135528)
41. Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer.
Han JY; Lim HS; Yoo YK; Shin ES; Park YH; Lee SY; Lee JE; Lee DH; Kim HT; Lee JS
Cancer; 2007 Jul; 110(1):138-47. PubMed ID: 17534875
[TBL] [Abstract][Full Text] [Related]
42. Multidrug resistance-associated protein 2 (MRP2/ABCC2) haplotypes significantly affect the pharmacokinetics of tacrolimus in kidney transplant recipients.
Ogasawara K; Chitnis SD; Gohh RY; Christians U; Akhlaghi F
Clin Pharmacokinet; 2013 Sep; 52(9):751-62. PubMed ID: 23633119
[TBL] [Abstract][Full Text] [Related]
43. Association between genetic polymorphisms of SLCO1B1 and susceptibility to methimazole-induced liver injury.
Jin S; Li X; Fan Y; Fan X; Dai Y; Lin H; Cai W; Yang J; Xiang X
Basic Clin Pharmacol Toxicol; 2019 Dec; 125(6):508-517. PubMed ID: 31240859
[TBL] [Abstract][Full Text] [Related]
44. CYP3A5, ABCB1, and SLCO1B1 polymorphisms and pharmacokinetics and virologic outcome of lopinavir/ritonavir in HIV-infected children.
Rakhmanina NY; Neely MN; Van Schaik RH; Gordish-Dressman HA; Williams KD; Soldin SJ; van den Anker JN
Ther Drug Monit; 2011 Aug; 33(4):417-24. PubMed ID: 21743379
[TBL] [Abstract][Full Text] [Related]
45. Genetic polymorphisms of the adenosine triphosphate-binding cassette transporters (ABCG2, ABCB1) and gefitinib toxicity.
Tamura M; Kondo M; Horio M; Ando M; Saito H; Yamamoto M; Horio Y; Hasegawa Y
Nagoya J Med Sci; 2012 Feb; 74(1-2):133-40. PubMed ID: 22515119
[TBL] [Abstract][Full Text] [Related]
46. Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics.
Niemi M; Backman JT; Kajosaari LI; Leathart JB; Neuvonen M; Daly AK; Eichelbaum M; Kivistö KT; Neuvonen PJ
Clin Pharmacol Ther; 2005 Jun; 77(6):468-78. PubMed ID: 15961978
[TBL] [Abstract][Full Text] [Related]
47. Polymorphisms in ATP-binding cassette transporter genes and interaction with diet and life style factors in relation to colorectal cancer in a Danish prospective case-cohort study.
Kopp TI; Andersen V; Tjonneland A; Vogel U
Scand J Gastroenterol; 2015; 50(12):1469-81. PubMed ID: 26109419
[TBL] [Abstract][Full Text] [Related]
48. Transporter Genes and statin-induced Hepatotoxicity.
Choi SA; Kim JS; Park YA; Lee DH; Park M; Yee J; Chang Y; Song TJ; Gwak HS
Cardiovasc Drugs Ther; 2024 May; ():. PubMed ID: 38809397
[TBL] [Abstract][Full Text] [Related]
49. Exon sequencing and high resolution haplotype analysis of ABC transporter genes implicated in drug resistance.
Leschziner G; Zabaneh D; Pirmohamed M; Owen A; Rogers J; Coffey AJ; Balding DJ; Bentley DB; Johnson MR
Pharmacogenet Genomics; 2006 Jun; 16(6):439-50. PubMed ID: 16708052
[TBL] [Abstract][Full Text] [Related]
50. Irinotecan toxicity during treatment of metastatic colorectal cancer: focus on pharmacogenomics and personalized medicine.
Paulík A; Nekvindová J; Filip S
Tumori; 2020 Apr; 106(2):87-94. PubMed ID: 30514181
[TBL] [Abstract][Full Text] [Related]
51. High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1).
Niemi M; Schaeffeler E; Lang T; Fromm MF; Neuvonen M; Kyrklund C; Backman JT; Kerb R; Schwab M; Neuvonen PJ; Eichelbaum M; Kivistö KT
Pharmacogenetics; 2004 Jul; 14(7):429-40. PubMed ID: 15226675
[TBL] [Abstract][Full Text] [Related]
52. Effects of ABCC2 and SLCO1B1 Polymorphisms on Treatment Responses in Thai Metastatic Colorectal Cancer Patients Treated with Irinotecan-Based Chemotherapy.
Treenert A; Areepium N; Tanasanvimon S
Asian Pac J Cancer Prev; 2018 Oct; 19(10):2757-2764. PubMed ID: 30360603
[TBL] [Abstract][Full Text] [Related]
53. Influence of drug-transporter polymorphisms on the pharmacokinetics of fexofenadine enantiomers.
Akamine Y; Miura M; Sunagawa S; Kagaya H; Yasui-Furukori N; Uno T
Xenobiotica; 2010 Nov; 40(11):782-9. PubMed ID: 20839930
[TBL] [Abstract][Full Text] [Related]
54. Update on drug transporter proteins in acute myeloid leukemia: Pathological implication and clinical setting.
Vasconcelos FC; de Souza PS; Hancio T; de Faria FCC; Maia RC
Crit Rev Oncol Hematol; 2021 Apr; 160():103281. PubMed ID: 33667660
[TBL] [Abstract][Full Text] [Related]
55. Influence of ABCB1, ABCC1, ABCC2, and ABCG2 haplotypes on the cellular exposure of nelfinavir in vivo.
Colombo S; Soranzo N; Rotger M; Sprenger R; Bleiber G; Furrer H; Buclin T; Goldstein D; Décosterd L; Telenti A;
Pharmacogenet Genomics; 2005 Sep; 15(9):599-608. PubMed ID: 16041239
[TBL] [Abstract][Full Text] [Related]
56. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
[TBL] [Abstract][Full Text] [Related]
57. Pharmacogenetics of ABCB1, CDA, DCK, GSTT1, GSTM1 and outcomes in a cohort of pediatric acute myeloid leukemia patients from Colombia.
Yunis LK; Linares-Ballesteros A; Aponte N; Barros G; García J; Niño L; Uribe G; Quintero E; Yunis JJ
Cancer Rep (Hoboken); 2023 Mar; 6(3):e1744. PubMed ID: 36316809
[TBL] [Abstract][Full Text] [Related]
58. Association of ABCB1 polymorphisms with the efficacy of ondansetron in chemotherapy-induced nausea and vomiting.
He H; Yin JY; Xu YJ; Li X; Zhang Y; Liu ZG; Zhou F; Zhai M; Li Y; Li XP; Wang Y; Zhou HH; Liu ZQ
Clin Ther; 2014 Aug; 36(8):1242-1252.e2. PubMed ID: 25012726
[TBL] [Abstract][Full Text] [Related]
59. Impact of novel polymorphisms related to cytotoxicity of cytarabine in the induction treatment of acute myeloid leukemia.
Megías-Vericat JE; Montesinos P; Herrero MJ; Moscardó F; Bosó V; Martínez-Cuadrón D; Poveda JL; Sanz MÁ; Aliño SF
Pharmacogenet Genomics; 2017 Jul; 27(7):270-274. PubMed ID: 28570300
[TBL] [Abstract][Full Text] [Related]
60. Prevalence of dyslipidemia and gene polymorphisms of ABCB1 and SLCO1B1 in Han, Uygur, Kazak, Hui, Tatar, Kirgiz, and Sibe populations with coronary heart disease in Xinjiang, China.
Wang T; Sun L; Xu L; Zhao T; Feng J; Yu L; Wu J; Li H
Lipids Health Dis; 2021 Sep; 20(1):116. PubMed ID: 34563206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]